Abstract
Background: The goal of this study was to compare the value of contrast-enhanced MRI and O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET for response assessment in glioma patients following adjuvant temozolomide chemotherapy (TMZ). Methods: After biopsy or resection and completion of radiotherapy with concomitant TMZ, 41 newly diagnosed and histomolecularly characterized glioma patients (glioblastoma, 90%; age range, 20-79 years) were subsequently treated with adjuvant TMZ. MR and 18F-FET PET imaging were performed at baseline and after the second cycle of adjuvant TMZ. We obtained 18F-FET metabolic tumor volumes (MTV) as well as mean and maximum tumor-to-brain ratios (TBRmean, TBRmax). Threshold values of 18F-FET PET parameters to predict outcome were established by ROC analyses using a median progression-free survival (PFS) of ≥9 months and overall survival (OS) of ≥15 months as reference. MRI response assessment was based on RANO criteria. The predictive value of changes of 18F-FET PET and MRI parameters on survival was evaluated subsequently using univariate and multivariate survival estimates. Results: After two cycles of adjuvant TMZ chemotherapy, a treatment-induced reduction of MTV and TBRmax predicted a significantly longer PFS and OS (both P ≤ 0.03; univariate survival analyses) while RANO criteria were not significant (P > 0.05). Multivariate survival analysis revealed that TBRmax changes predicted a prolonged PFS (P = 0.012) and changes of MTV a prolonged OS (P = 0.005) independent of O6-methylguanine-DNA-methyltransferase promoter methylation and other strong prognostic factors. Conclusion: Changes of 18F-FET PET parameters appear to be helpful for identifying responders to adjuvant TMZ early after treatment initiation.
- Neurology
- Oncology: Brain
- PET
- Amino acid PET
- metabolic tumor volume
- pseudoprogression
- treatment monitoring
- treatment-related changes
- Copyright © 2020 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user